Latest Insider Transactions at Brookline Capital Acquisition Corp. (BCAC)
This section provides a real-time view of insider transactions for Brookline Capital Acquisition Corp. (BCAC). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Brookline Capital Acquisition Corp. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Brookline Capital Acquisition Corp.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 23
2023
|
Frank J. Hsu Chief Medical Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
16,354
-100.0%
|
-
|
|
Aug 23
2023
|
Francis Willard Sarena President and COO |
SELL
Sale (or disposition) back to the issuer
|
Direct |
124,296
-100.0%
|
-
|
|
Aug 23
2023
|
Francis Willard Sarena President and COO |
SELL
Payment of exercise price or tax liability
|
Direct |
31,123
-20.03%
|
$0
$0.39 P/Share
|
|
Aug 23
2023
|
Amy Wong SVP, Finance and Operations |
SELL
Sale (or disposition) back to the issuer
|
Direct |
66,565
-100.0%
|
-
|
|
Aug 23
2023
|
Amy Wong SVP, Finance and Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
15,561
-18.95%
|
$0
$0.39 P/Share
|
|
Aug 23
2023
|
Gordon Ringold Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
10,000
-100.0%
|
-
|
|
Aug 23
2023
|
Samuel P Wertheimer Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
146,383
-100.0%
|
-
|
|
Aug 23
2023
|
William E. Duke Chief Financial Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
128,001
-100.0%
|
-
|
|
Aug 23
2023
|
William E. Duke Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
26,416
-17.11%
|
$0
$0.39 P/Share
|
|
Aug 23
2023
|
Xiaodong Yang Chief Executive Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
863,729
-100.0%
|
-
|
|
Aug 23
2023
|
Xiaodong Yang Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
69,161
-7.41%
|
$0
$0.39 P/Share
|
|
Aug 23
2023
|
Xiaodong Yang Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
400,000
+30.01%
|
-
|
|
Jun 15
2023
|
Xiaodong Yang Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
7,001
-1.3%
|
$0
$0.49 P/Share
|
|
Jun 15
2023
|
Amy Wong SVP, Finance and Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
2,777
-3.27%
|
$0
$0.49 P/Share
|
|
Jun 15
2023
|
William E. Duke Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,504
-2.83%
|
$0
$0.49 P/Share
|
|
Jun 15
2023
|
Frank J. Hsu Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,323
-20.91%
|
$0
$0.49 P/Share
|
|
Jun 15
2023
|
Francis Willard Sarena President and COO |
SELL
Payment of exercise price or tax liability
|
Direct |
6,917
-4.26%
|
$0
$0.49 P/Share
|
|
May 23
2023
|
Amy Wong SVP, Finance and Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
12,234
-12.59%
|
$0
$0.4 P/Share
|
|
May 23
2023
|
Amy Wong SVP, Finance and Operations |
BUY
Grant, award, or other acquisition
|
Direct |
75,000
+43.57%
|
-
|
|
May 23
2023
|
William E. Duke Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
17,261
-9.8%
|
$0
$0.4 P/Share
|
|
May 23
2023
|
William E. Duke Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
150,000
+45.99%
|
-
|
|
May 23
2023
|
Francis Willard Sarena President and COO |
SELL
Payment of exercise price or tax liability
|
Direct |
20,748
-11.33%
|
$0
$0.4 P/Share
|
|
May 23
2023
|
Francis Willard Sarena President and COO |
BUY
Grant, award, or other acquisition
|
Direct |
150,000
+45.03%
|
-
|
|
Jan 26
2023
|
Samuel P Wertheimer Director |
BUY
Other acquisition or disposition
|
Direct |
146,383
+50.0%
|
-
|
|
Dec 15
2022
|
Frank J. Hsu Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,323
-17.29%
|
$4,323
$1.06 P/Share
|
|
Dec 15
2022
|
Francis Willard Sarena President and COO |
SELL
Payment of exercise price or tax liability
|
Direct |
6,916
-17.29%
|
$6,916
$1.06 P/Share
|
|
Dec 15
2022
|
Amy Wong SVP, Finance and Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
2,851
-17.29%
|
$2,851
$1.06 P/Share
|
|
Dec 15
2022
|
Xiaodong Yang Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
7,001
-1.3%
|
$7,001
$1.06 P/Share
|
|
Dec 15
2022
|
William E. Duke Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,503
-14.67%
|
$4,503
$1.06 P/Share
|
|
Oct 07
2022
|
Amy Wong SVP, Finance and Operations |
BUY
Grant, award, or other acquisition
|
Direct |
16,488
+50.0%
|
-
|
|
Oct 07
2022
|
Francis Willard Sarena President and COO |
BUY
Grant, award, or other acquisition
|
Direct |
40,000
+50.0%
|
-
|
|
Oct 07
2022
|
Frank J. Hsu Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+50.0%
|
-
|
|
Oct 07
2022
|
William E. Duke Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
30,685
+50.0%
|
-
|
|
Oct 07
2022
|
Xiaodong Yang Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
40,488
+6.99%
|
-
|
|
Feb 11
2021
|
Glazer Capital, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
400,000
-64.0%
|
$4,400,000
$11.31 P/Share
|
|
Feb 02
2021
|
Brookline Capital Holdings LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
247,000
+13.18%
|
$2,470,000
$10.0 P/Share
|